Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Martinez

Showing results (631-640 of 706) with videos related to

Pageof 71
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2023
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and ProposalsStefanie T Jost, Marie-Ann Kaldenbach, Angelo Antonini, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
The European Respiratory Journal|April 23, 2016
Prognostic assessment in COPD without lung function: the B-AE-D indicesLucas Boeck, Joan B Soriano, Marjolein Brusse-Keizer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2019
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrumIsabelle Bos, Stephanie Vos, Frans Verhey, et al.
The Lancet. Respiratory Medicine|May 22, 2015
Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient dataJoan B Soriano, Bernd Lamprecht, Ana S Ramírez, et al.
Fluids and Barriers of the CNS|July 17, 2024
Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studiesAurore Delvenne, Charysse Vandendriessche, Johan Gobom, et al.
Molecular Neurodegeneration|March 29, 2022
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
International Journal of Environmental Research and Public Health|November 21, 2019
Ten Lessons for Good Practice for the INHERIT Triple Win: Health, Equity, and Environmental SustainabilityRuth Bell, Matluba Khan, Maria Romeo-Velilla, et al.
Future Oncology (London, England)|November 12, 2024
Plain language summary: tarlatamab for patients with previously treated small cell lung cancerMyung-Ju Ahn, Byoung Chul Cho, Enriqueta Felip, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 26, 2020
The impact of freezing of gait on functional dependency in Parkinson's disease with regard to motor phenotypeDiego Santos-García, Teres de Deus-Fonticoba, Ester Suárez Castro, et al.
Pageof 71

Showing results (631-640 of 706) with videos related to

Sort By:
Pageof 71
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2023
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and ProposalsStefanie T Jost, Marie-Ann Kaldenbach, Angelo Antonini, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
The European Respiratory Journal|April 23, 2016
Prognostic assessment in COPD without lung function: the B-AE-D indicesLucas Boeck, Joan B Soriano, Marjolein Brusse-Keizer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2019
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrumIsabelle Bos, Stephanie Vos, Frans Verhey, et al.
The Lancet. Respiratory Medicine|May 22, 2015
Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient dataJoan B Soriano, Bernd Lamprecht, Ana S Ramírez, et al.
Fluids and Barriers of the CNS|July 17, 2024
Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studiesAurore Delvenne, Charysse Vandendriessche, Johan Gobom, et al.
Molecular Neurodegeneration|March 29, 2022
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
International Journal of Environmental Research and Public Health|November 21, 2019
Ten Lessons for Good Practice for the INHERIT Triple Win: Health, Equity, and Environmental SustainabilityRuth Bell, Matluba Khan, Maria Romeo-Velilla, et al.
Future Oncology (London, England)|November 12, 2024
Plain language summary: tarlatamab for patients with previously treated small cell lung cancerMyung-Ju Ahn, Byoung Chul Cho, Enriqueta Felip, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 26, 2020
The impact of freezing of gait on functional dependency in Parkinson's disease with regard to motor phenotypeDiego Santos-García, Teres de Deus-Fonticoba, Ester Suárez Castro, et al.
Pageof 71